XML 20 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
Additional Paid-in Capital
Loan receivables - related parties
Retained Earnings - Statutory Reserves
Retained Earnings - Unrestricted
AOCI Attributable to Parent
Noncontrolling Interest
Total
Common Class A
Common Class B
Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2021 $ 332,574 $ (4,683,530) $ 188,833 $ 16,352,598 $ 32,147 $ (1,170) $ 12,222,952 $ 1,044 $ 456
Shares, Outstanding, Beginning Balance at Dec. 31, 2021               10,440,000 4,560,000
Repayments from loans receivable - related parties 0 3,812,241 0 0 0 0 3,812,241 $ 0 $ 0
Dividends declared to offset with loans receivable-related parties 0 951,209 0 0 0 0 951,209 0 0
Dividends declared 0 0 0 (4,470,111) 0 0 (4,470,111) 0 0
Net (loss) income 0 0 0 2,851,467 0 (10,333) 2,841,134 0 0
Stock Holders Equity Statutory Reserves 0 0 51,591 (51,591) 0 0 0 0 0
Foreign currency translation adjustment 0 (79,920) 0 0 (430,893) (2,932) (513,745) 0 0
Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Dec. 31, 2022 332,574 0 240,424 14,682,363 (398,746) (14,435) 14,843,680 $ 1,044 $ 456
Shares, Outstanding, Ending Balance at Dec. 31, 2022               10,440,000 4,560,000
Proceeds from issuance of shares upon IPO             0    
Proceeds from issuance of shares pursuant to exercise of over-allotment             0    
Repayments from loans receivable - related parties             0    
Net (loss) income 0 0 0 856,536 0 (99,775) 756,761 $ 0 $ 0
Stock Holders Equity Statutory Reserves 0 0 8,337 (8,337) 0 0 0 0 0
Foreign currency translation adjustment 0 0 0   114,302 (303) 113,999 0 0
Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Dec. 31, 2023 332,574 0 248,761 15,530,562 (284,444) (114,513) 15,714,440 $ 1,044 $ 456
Shares, Outstanding, Ending Balance at Dec. 31, 2023               10,440,000 4,560,000
Proceeds from issuance of shares upon IPO             0    
Proceeds from issuance of shares pursuant to exercise of over-allotment             0    
Repayments from loans receivable - related parties             0    
Net (loss) income       (480,019)   (91,698) (571,717)    
Foreign currency translation adjustment 0 0 0 0 (727,743) (7,388) (735,131) $ 0 $ 0
Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Dec. 31, 2024 3,135,124 0 248,761 15,050,543 (1,012,187) (163,599) 17,260,277 $ 1,179 $ 456
Shares, Outstanding, Ending Balance at Dec. 31, 2024               11,793,485 4,560,000
Proceeds from issuance of shares upon IPO 4,999,875 0 0 0 0 0 5,000,000 $ 125 $ 0
Share issuance upon initial public offering ('IPO')               1,250,000  
Issuance of Stock and Warrants for Services or Claims 202,346 0 0 0 0 0 202,346    
Proceeds from issuance of shares pursuant to exercise of over-allotment 413,930 0 0 0 0 0 413,940 $ 10 0
Share issuance pursuant to exercise of over-allotment               103,485  
Offering cost incurred for IPO and over-allotment (2,813,601) 0 0 0 0 0 (2,813,601) $ 0 0
Capital contribution from noncontrolling shareholder $ 0 $ 0 $ 0 $ 0 $ 0 $ 50,000 $ 50,000 $ 0 $ 0